P. Borowiecki et al. / Tetrahedron xxx (2013) 1e6
5
chromatography was performed using Silica gel 60 (Merck) of
40e63 m. A mixture of 20% ethyl acetate/hexane was used as el-
461, 425 cmꢁ1; NMR dH (400 MHz, CDCl3) 1.35 (3H, d, J¼6.32 Hz,
CH3), 3.34 (1H, dd, J¼14.34, 7.11 Hz, CH2), 3.51 (1H, dd, J¼14.23,
3.16 Hz, CH2) 3.88 (1H, br s, OH), 4.21e4.30 (1H, m, CH), 7.27e7.45
(2H, m, Ph), 7.70e7.87 (2H, m, Ph); NMR dC (100 MHz, CDCl3) 22.5,
42.1, 67.4, 121.0, 121.2, 124.6, 126.2, 135.3, 152.3, 167.7; HRMS (ESIþ,
m/z): [MþH]þ, found 225.9984. C10H11NOS2 requires 226.0355;
HPLC [hexane/i-PrOH (95:5); f¼0.4 mL/min]: tR¼41.4 min,
45.2 min.
m
uent. The enantiomeric excesses of resulting esters and alcohols
were determined by HPLC analysis performed on Shimadzu CTO-
10ASV chromatograph equipped with STD-20A UV detector and
Chiralcel OD-H (Diacel) chiral column using mixtures of n-hexane/
iso-propyl alcohol as mobile phase in appropriate ratios given in
experimental section; the HPLC analyses were executed in an iso-
cratic manner; flow (f) is given in mL/min; retention times (tR) are
given in minutes under conditions given; racemic alcohols and
esters were used as standards. Optical rotations were measured
with an AP-300 automatic polarimeter (ATAGO) in a 0.5 dm long
cuvette. UV spectra were measured with Cary 3 spectrometer (data
were collected on diluted solutions in quartz spectroscopy cells). 1H
and 13C NMR spectra were measured with a Varian Mercury 400BB
spectrometer operating at 400 MHz for 1H and 100 MHz for 13C
4.1.3. 1-(1,3-Benzothiazol-2-ylsulfanyl)propan-2-yl acetate ((ꢀ)-5).
To a solution of 1-(1,3-benzothiazol-2-ylsulfanyl)propan-2-ol (ꢀ)-4
(3 g, 13.3 mmol) in toluene (30 mL) acetyl chloride (1.04 g,
13.3 mmol) and subsequently triethylamine (1.35 g, 13.3 mmol)
were added with stirring at room temperature. The reaction mix-
ture was stirred at reflux for 3 h, then cooled to room temperature,
and the precipitated triethylamine hydrochloride salt was filtered
off. Next, the permeate was concentrated in vacuo and crude
product was purified by gel chromatography (20% ethyl acetate/
hexane) yielding the title compound (ꢀ)-5 (2.85 g, 80%) as a light-
green oil; Rf (20% ethyl acetate/hexane) 0.53; FTIR nmax(neat):
2981, 1734, 1456, 1426, 1369, 1309, 1228, 1126, 1036, 991, 955, 753,
725, 673, 606, 429 cmꢁ1; NMR dH (400 MHz, CDCl3) 1.40 (3H, d,
J¼6.32 Hz, CHCH3), 2.02 (3H, s, (C]O)CH3), 3.49 (1H, dd, J¼13.89,
6.89 Hz, CH2), 3.70 (1H, dd, J¼13.78, 4.74 Hz, CH2), 5.27 (1H, td,
J¼6.49, 4.86 Hz, CH), 7.27e7.46 (2H, m, Ph), 7.72e7.90 (2H, m, Ph);
NMR dC (100 MHz, CDCl3) 19.3, 21.2, 38.1, 69.1, 120.9, 121.4, 124.3,
126.0, 135.2, 152.8, 166.0, 170.2; HRMS (ESIþ, m/z): [MþH]þ, found
268.0106. C12H13NO2S2 requires 268.0461; HPLC [hexane/i-PrOH
(95:5); f¼0.4 mL/min]: tR¼18.6 min, 26.6 min.
nuclei, chemical shifts (d) are given in parts per million (ppm) re-
lated to tetramethylsilane (TMS) as internal standard; signal mul-
tiplicity assignment: s, singlet; d, doublet; t, triplet; q, quartet; m,
multiplet; coupling constant (J) are given in hertz (Hz). Mass
spectra were recorded with a Micro-mass ESI Q-TOF spectrometer
at the Mass Spectrometry Laboratory, Institute of Biochemistry and
Biophysics (IBB), PAN. IR spectra of neat samples were recorded on
a PerkineElmer System 2000 FTIR Spectrometer equipped with
a Pike Technologies GladiATRÔ attenuated total reflectance (ATR)
accessory with a monolithic diamond crystal stage and a pressure
clamp.
4.1.1. 1-(1,3-Benzothiazol-2-ylsulfanyl)propan-2-one (3). In a three-
necked round bottom flask equipped with a reflux condenser
ethanolic (66 mL) solution of 1,3-benzothiazole-2-thiol 1 (5 g,
29.9 mmol) was placed. Then potassium hydroxide (1.68 g,
29.9 mmol) was added and the mixture was stirred at 80 ꢂC for
15 min in a gentle stream of dry nitrogen. After cooling the con-
tents of the flask to room temperature chloroacetone 2 (2.77 g,
29.9 mmol) was added and stirring was continued for an addi-
tional 20 h. Next, crude reaction mixture was poured into ice-
water (66 mL) and kept at 0e10 ꢂC for 30 min with stirring. A
yellow precipitate was filtered off, quenched with distilled H2O
(15 mL), and dried at ambient temperature to give desired ketone.
Further purification of the crude product by recrystallization
process from EtOH gave the title compound 3 (5.2 g, 78%) as
a white solid, mp 64e64.5 ꢂC (ethanol) (lit.10 mp 64e65 ꢂC, eth-
anol); Rf (20% ethyl acetate/hexane) 0.38; FTIR nmax(neat): 2967,
1717, 1463, 1427, 1357, 1298, 1232, 1152, 1073, 997, 753, 703, 673,
577, 436, 406 cmꢁ1; NMR dH (400 MHz, CDCl3) 2.40 (3H, s, CH3),
4.26 (2H, s, CH2), 7.28e7.45 (2H, m, Ph), 7.72e7.87 (2H, m, Ph); dC
(100 MHz, CDCl3) 28.8, 43.1, 121.1, 121.5, 124.5, 126.1, 135.4, 152.5,
165.1, 201.7; HRMS (ESIþ, m/z): [MþH]þ, found 223.9879.
4.1.4. Enzymatic transesterification of ((ꢀ)-4). Racemic alcohol
(ꢀ)-4 (100 mg, 0.44 mmol) was dissolved in corresponding organic
solvent (3 mL) as stated in Table 1. Afterward, suspension of lipase
(5e10 mg) and vinyl acetate (50 mg, 0.57 mmol) were added in one
portion. The reaction mixture was shaken (250 rpm) at 32 ꢂC, and
its aliquots were regularly analyzed by gas chromatography. The
reaction was stopped by filtering off the catalyst and the enzyme
was washed using the solvent (3 mL) as applied previously. After
evaporation of the filtrate under reduced pressure, the components
of the mixture were separated by a silica gel column chromatog-
raphy (20% ethyl acetate/hexane) affording enantiomerically
enriched alcohol (S)-(ꢁ)-4a and ester (R)-(þ)-4b, respectively. For
additional data, see Table 1.
4.1.5. Enzymatic hydrolysis of ((ꢀ)-5). Ester (ꢀ)-5 (200 mg,
0.75 mmol) was dissolved in wateresaturated TBME (6 mL).
Novozym SP 435 (20 mg) was added in one portion, and then the
suspension was kept under shaking (250 rpm) with incubation at
32 ꢂC for the amount of time given in Table 2. The degree of hy-
drolysis was followed by GC analysis of the properly treated sample
accordingly to the procedure as given in the text below. The re-
action was terminated by filtering off the enzyme. The phases were
separated and the extraction of the aqueous solution with AcOEt
(3ꢃ5 mL) was performed. The combined organic phases were dried
(MgSO4), filtered, and then concentrated under vacuum. The puri-
fication of the resulting residue by column chromatography [20%
C
10H9NOS2 requires 224.0198.
4.1.2. 1-(1,3-Benzothiazol-2-ylsulfanyl)propan-2-ol
((ꢀ)-4). In
a
two-necked round bottom flask 1-(1,3-benzothiazol-2-
ylsulfanyl)propan-2-one 3 (0.73 g, 3.3 mmol) was dissolved in
methanol (40 mL) and kept under an atmosphere of nitrogen at
ice-water temperature. Subsequently, sodium borohydride (0.6 g,
15.9 mmol) was added portionwise with stirring at a rate sufficient
to maintain the internal temperature at 5 ꢂC. The reaction mixture
was stirred at 0e5 ꢂC for 2 h. Next, the methyl alcohol was
evaporated in vacuo, the residue was suspended in distilled H2O
(30 mL) and extracted with EtOAc (3ꢃ20 mL). The organic layers
were combined and dried (MgSO4). After filtration through short
silica pad and the solvent evaporation under reduced pressure, the
final product (ꢀ)-4 was obtained (0.62 g, 85%) as an orange oil; Rf
(20% ethyl acetate/hexane) 0.22; FTIR nmax(neat): 3346, 2966,
2868, 1452, 1423, 1245, 1127, 1043, 1002, 943, 752, 686, 598, 580,
ethyl acetate/hexane] afforded enantioenriched ester (S)-(ꢁ)-5b
29
[ee¼92%; [
a
]
ꢁ14.86 (c 1.0, CHCl3)] and alcohol (R)-(þ)-5a
þ25.54 (c 1.0, CHCl3)].
D
29
[ee>99%; [
a]
D
4.1.6. Esterification of (R)-(þ)-5a with (R)- or (S)-MPA. A catalytic
amount of DMAP (5 mg) and DCC (44 mg, 0.213 mmol) were added
to the solution of (R)-(þ)-1-(1,3-benzothiazol-2-ylsulfanyl)propan-
2-ol (R)-(þ)-5a (40 mg, 0.178 mmol) and (R)- or (S)-
a-methoxy-a-
phenylacetic acid (29 mg, 0.178 mmol) in dry CH2Cl2 (3 mL), re-
spectively. After 48 h of stirring at room temperature, precipitated